Intensive Treatment Versus Standard Weekly Prolonged Exposure for Adults With Post-Traumatic Stress Disorder - Trial NCT05934175
Access comprehensive clinical trial information for NCT05934175 through Pure Global AI's free database. This phase not specified trial is sponsored by Karolinska Institutet and is currently Not yet recruiting. The study focuses on Post Traumatic Stress Disorder. Target enrollment is 140 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Karolinska Institutet
Timeline & Enrollment
N/A
Aug 20, 2023
Aug 20, 2026
Primary Outcome
Change in PTSD symptoms as assessed by the Clinician Administered PTSD Scale (CAPS-5)
Summary
The goal of this clinical trial is to compare a novel, massed treatment format of prolonged
 exposure to gold standard trauma focused cognitive behavioral therapy (weekly delivered
 prolonged exposure) for post-traumatic stress disorder.
 
 The objective with this study is to investigate efficacy, mechanisms of change and cost
 effectiveness of intensive prolonged exposure (I-PE) in regular Swedish psychiatric care.
 
 Adult patients with post-traumatic stress disorder will be randomly assigned to receive
 either gold standard prolonged exposure weekly for 15 weeks or 5 days of intensive treatment
 with the addition of three booster sessions dispersed 1, 2 and 4 weeks after completion of
 the massed treatment period.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05934175
Non-Device Trial